‘Mass Spectrometry Market Worth Over $3.8 Billion In 2017’ Says Visiongain Report

28 August 2017
Pharma

Visiongain’s new report The Mass Spectrometry Market Forecast 2017-2027 – Revenue Prospects by Technology (Single, Ion Trap, Quadrupole, TOF, Hybrid, Triple Quadrupole, Q-TOF, FTMS), by Application (Academia, Biotech, Agriculture, CRO, Hospitals, Environmental, Materials) and Geography indicates that the global mass spectrometry market will see over $3.8bn in revenue in 2017.

The lead analyst of the report said:

“The mass spectrometry market is expected to experience considerable growth over the forecast period. The main drivers for the growth include the applications of the mass spectrometry in wide range of areas, technological advancements and adoption/acceptability of new technology by the government to address the healthcare challenges. The increasing disease burden and identification of antibacterial resistant strains is leading to therapeutical advancements, drug discovery and increase research and development activities to address this situation. The high-speed, accurate, sample analysis of simple to complex molecules/products by the mass spectrometry is leading to its increased demand in the areas such as clinical research, proteomic, metabolomics, and forensics including many others.”
The 183-page report contains 111 tables, charts and graphs that add visual analysis in order to explain developing trends within the mass spectrometry market. Visiongain provides revenue forecasts for the period 2017-2027 for the leading mass spectrometry submarkets, segmented by technology, with forecasts for single and hybrid mass spectrometry. The market is also segmented by product, and includes forecasts for Ion Trap, Quadrupole, TOF, Triple Quadrupole, Quadrupole-TOF and Fourier Transform Mass Spectrometry. The report also includes forecasts for the applications of mass spectrometry, including academic, biotech, agriculture, contract research, hospital, environmental and material usage.

The 183-page report offers market forecasts and analysis for 4 regional and 12 national markets. In addition, the report contains a dedicated leading companies’ chapter covering 10 companies leading the field in mass spectrometry technology.

The Mass Spectrometry Market Forecast 2017-2027 – Revenue Prospects by Technology (Single, Ion Trap, Quadrupole, TOF, Hybrid, Triple Quadrupole, Q-TOF, FTMS), by Application (Academia, Biotech, Agriculture, CRO, Hospitals, Environmental, Materials) and Geography report will be of value to anyone who wants to better understand the mass spectrometry market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the mass spectrometry industry.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

Read

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

Read

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

Read

Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever